Volume 23, Number 1Men's HealthContemporary Management of Male HypogonadismAndrew Y SunMale hypogonadism affects up to 40% of men and is becoming more prominent because of increasingly prevalent medical comorbidities. Because various forms of treatment are available today, physicians should discuss drug efficacy and safety while simultaneously ensuring that therapy forms are in alignment with patient preferences. Treatment adherence is critical to sustaining patient health outcomes.HypogonadismHormone replacementtestosterone deficiency
Volume 2, Number 2Review ArticlesRelationship Between Testosterone and Erectile DysfunctionClinical TherapeuticsJacob RajferTestosteroneHypogonadismErectile dysfunctionImpotenceAndrogens, synthetic
Volume 4, Supplement 3SupplementUrological and Medical Evaluation of Men with Erectile DysfunctionCulley C CarsonHypogonadismErectile dysfunctionDuplex Doppler ultrasonographyLow
Volume 4, Supplement 3SupplementIntroductionAndrew R McCulloughHypogonadismErectile dysfunctionDuplex Doppler ultrasonographyLow
Volume 5, Number 4Review ArticlesAndrogen Replacement Therapy in the Aging MaleTreatment UpdateRandall B MeachamJeremy B MyersDepressionAndrogenTestosteroneHypogonadismErectile dysfunctionAndropauseHormone replacementMale osteoporosisProstatecancerSarcopenia
Volume 5, Supplement 1SupplementFundamental Aspects of Hypogonadism in the Aging MaleAlvin M MatsumotoTestosteroneHypogonadismAgingLuteinizing hormoneSex hormone-binding globulinAndrogen receptor
Volume 5, Supplement 1SupplementAndrogen Supplementation and Prostate Cancer Risk: Strategies for Pretherapy Assessment and MonitoringMichael K BrawerProstate cancerProstate-specific antigenHypogonadismDihydrotestosteroneAndrogen replacement5-Alpha-reductase
Volume 5, Supplement 1SupplementNew Advances in the Treatment of Hypogonadism in the Aging MaleChristopher P SteidleTestosterone replacement therapyHypogonadismErectile dysfunctionOsteoporosisAndropause syndrome
Volume 5, Supplement 1SupplementCase Scenarios in Androgen DeficiencyAndrew R McCulloughProstate cancerHypogonadismErectile dysfunctionAndrogen replacementPartial androgen deficiency
Volume 6, Number 4Point-CounterpointThe Role of Routine Serum Testosterone Testing: Routine Hormone Analysis Is Not Indicated as an Initial Screening Test in the Evaluation of Erectile DysfunctionScott I ZeitlinGregory S JackTestosteroneHypogonadismErectile dysfunction